Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-05-22
1998-12-08
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514324, 546193, 546202, A61K 3143, A61K 3144, C07D40904, C07D40104
Patent
active
058469826
ABSTRACT:
This invention provides compounds and a method for the inhibition of serotonin reuptake in mammals.
REFERENCES:
patent: 3974280 (1976-08-01), Bernasconi
patent: 4195081 (1980-03-01), Nedelec et al.
patent: 4196209 (1980-04-01), Dumont et al.
patent: 4232031 (1980-11-01), Dument et al.
patent: 4278677 (1981-07-01), Nedelec et al.
patent: 4324790 (1982-04-01), Guillaume et al.
patent: 4333939 (1982-06-01), Guillaume et al.
patent: 5409940 (1995-04-01), Hulkenberg et al.
patent: 5521197 (1996-05-01), Audia
patent: 5532240 (1996-07-01), Nakao et al.
patent: 5576321 (1996-11-01), Krushinski, Jr. et al.
Chemical Abstracts, vol. 83(19),abst.No. 163,998J,Nov. 10, 1975.
Malleron, J., J. Med. Chem. 1993, vol. 36, pp. 1194-1202.
Redrobe, J., Euro, J. Pharmacol., Dec. 30, 1996, vol. 318, pp. 213-220.
Audia James E.
Koch Daniel J.
Mabry Thomas E.
Nissen Jeffrey S.
Rocco Vincent P.
Boone David E.
Eli Lilly and Company
Rotman Alan L.
Titus Robert D.
LandOfFree
Inhibition of serotonin reuptake does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of serotonin reuptake, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of serotonin reuptake will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-177541